Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

NCT06257758 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT06257758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Lead sponsor
Valerio Therapeutics
Phase
Phase 1/2
Overall status
Terminated
Start date
January 10, 2024
Completion date
January 1, 2025
Enrollment
6 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic solid tumors, breast cancer, prostate cancer, recurrent ovarian cancer